{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:13:04Z","timestamp":1768410784918,"version":"3.49.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002674","name":"Russian Academy of Sciences","doi-asserted-by":"publisher","award":["01201353020"],"award-info":[{"award-number":["01201353020"]}],"id":[{"id":"10.13039\/501100002674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007840","name":"Moscow State University of Geodesy and Cartography","doi-asserted-by":"publisher","award":["121032300075-6"],"award-info":[{"award-number":["121032300075-6"]}],"id":[{"id":"10.13039\/501100007840","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.npep.2022.102287","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T11:30:58Z","timestamp":1663241458000},"page":"102287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["HLDF-6 peptides exhibit neuroprotective effects in the experimental model of preclinical Parkinson's disease"],"prefix":"10.1016","volume":"96","author":[{"given":"Yurii A.","family":"Zolotarev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislav I.","family":"Shram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandr K.","family":"Dadayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg V.","family":"Dolotov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitriy D.","family":"Markov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor Yu.","family":"Nagaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir S.","family":"Kudrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor B.","family":"Narkevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg Yu.","family":"Sokolov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalya V.","family":"Kost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2022.102287_bb0005","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1590\/0004-282X20150057","article-title":"Neuroinflammation in the pathophysiology of Parkinson\u2019s disease and therapeutic evidence of anti-inflammatory drugs","volume":"73","author":"Bassani","year":"2015","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.npep.2022.102287_bb0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nbd.2005.02.005","article-title":"Unraveling substantia nigra sequential gene expression in a progressive MPTP-lesioned macaque model of Parkinson\u2019s disease","volume":"20","author":"Bassilana","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.npep.2022.102287_bb0015","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1096\/fj.09-131789","article-title":"Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism","volume":"23","author":"Beurrier","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.npep.2022.102287_bb0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/0269881115616393","article-title":"Comparative study of the neuroprotective and nootropic activities of the carboxylate and amide forms of the HLDF-6 peptide in animal models of Alzheimer\u2019s disease","volume":"30","author":"Bogachouk","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.npep.2022.102287_bb0025","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.yfrne.2009.04.014","article-title":"Neuroprotective actions of sex steroids in Parkinson\u2019s disease","volume":"30","author":"Bourque","year":"2009","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.npep.2022.102287_bb0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.npep.2022.102287_bb0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","article-title":"Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNF\u03b1, and INF\u03b3 concentrations are elevated in patients with atypical and idiopathic parkinsonism","volume":"441","author":"Brodacki","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2022.102287_bb0040","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1134\/S1062360419050035","article-title":"Peptides regulation of protein synthesis kinetics improves the cell-cell communication by aging","volume":"50","author":"Brodsky","year":"2019","journal-title":"Russ. J. Dev. Biol."},{"key":"10.1016\/j.npep.2022.102287_bb0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1134\/S1062360420020034","article-title":"The peptides either semax or HLDF-6 injected to rats regulate protein synthesis rhythm in hepatocytes correcting senescent disturbances","volume":"51","author":"Brodsky","year":"2020","journal-title":"Russ. J. Dev. Biol."},{"key":"10.1016\/j.npep.2022.102287_bb0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/syn.1067","article-title":"Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl\/6 mice","volume":"41","author":"Callier","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.npep.2022.102287_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15789\/1563-0625-2005-1-77-84","article-title":"Modulation of functional macrophage activity by HLDF6 peptide upon adding opiate receptor agonists","volume":"7","author":"Danilenko","year":"2005","journal-title":"Med. Immunol."},{"key":"10.1016\/j.npep.2022.102287_bb0060","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1093\/brain\/awaa198","article-title":"Dopamine and reward hypersensitivity in Parkinson\u2019s disease with impulse control disorder","volume":"143","author":"Drew","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.npep.2022.102287_bb0065","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0006-8993(00)02999-1","article-title":"Time-course and dose-response study on the effects of chronic L-DOPA administration on striatal dopamine levels and dopamine transporter following MPTP toxicity","volume":"887","author":"Fornai","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2022.102287_bb0070","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/bs.irn.2017.05.021","article-title":"Nonmotor fluctuations in Parkinson\u2019s disease","volume":"134","author":"Franke","year":"2017","journal-title":"Int. Rev. Neurobiol"},{"key":"10.1016\/j.npep.2022.102287_bb0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00702-020-02287-8","article-title":"Effect of the mGlu2 positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset","volume":"128","author":"Frouni","year":"2021","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.npep.2022.102287_bb0080","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.yfrne.2014.02.002","article-title":"Sex differences in Parkinson\u2019s disease","volume":"35","author":"Gillies","year":"2014","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.npep.2022.102287_bb0085","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1523\/JNEUROSCI.18-15-05614.1998","article-title":"Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease","volume":"18","author":"Ho","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2022.102287_bb0090","first-page":"1","article-title":"Dynamic changes in the nigrostriatal pathway in the MPTP mouse model of Parkinson\u2019s disease","volume":"2017","author":"Huang","year":"2017","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.npep.2022.102287_bb0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"4","author":"Jackson-Lewis","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.npep.2022.102287_bb0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brainres.2008.12.081","article-title":"Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson\u2019s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"1261","author":"Joniec","year":"2009","journal-title":"Brain Res."},{"issue":"9996","key":"10.1016\/j.npep.2022.102287_bb0105","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet."},{"key":"10.1016\/j.npep.2022.102287_bb0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1134\/S1819712411010041","article-title":"Dopamine release in the substantia nigra and striatum at presymptomatic and early symptomatic stages in parkinsonian mice","volume":"5","author":"Khakimova","year":"2011","journal-title":"Neurochem. J."},{"key":"10.1016\/j.npep.2022.102287_bb0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2009.09.103","article-title":"Hwang O Vertical grid test and modified horizontal grid test are sensitive methods for evaluating motor dysfunctions in the MPTP mouse model of Parkinson\u2019s disease","volume":"1306","author":"Kim","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2022.102287_bb0120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.32607\/actanaturae.11433","article-title":"A mouse model of nigrostriatal dopaminergic axonal degeneration as a tool for testing neuroprotectors","volume":"13","author":"Kolacheva","year":"2021","journal-title":"Acta Nat."},{"key":"10.1016\/j.npep.2022.102287_bb0125","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0014-5793(94)01306-3","volume":"356","author":"Kostanyan","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.npep.2022.102287_bb0130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/BF02758614","article-title":"A biologically active fragment of the differentiation factor of the HL-60 line cells: identification and properties","volume":"26","author":"Kostanyan","year":"2000","journal-title":"Russ J Bioorg Chem"},{"key":"10.1016\/j.npep.2022.102287_bb0135","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1134\/S1068162006040066","article-title":"Neuroprotective effect of the hexapeptide HLDF-6 on rat hippocampal neurons on the in vivo and in vitro models of Alzheimer\u2019s disease","volume":"32","author":"Kostanyan","year":"2006","journal-title":"Russ J Bioorg Chem"},{"key":"10.1016\/j.npep.2022.102287_bb0140","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1134\/S0012496609050081","article-title":"Postischemic administration of HLDF-6 peptide ameliorates cognitive dysfunction and brain damage induced by chronic cerebral Ischemia in rats","volume":"428","author":"Kostanyan","year":"2009","journal-title":"Dokl. Biol. Sci."},{"key":"10.1016\/j.npep.2022.102287_bb0145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1134\/S1068162021010118","article-title":"Influence of sub-chronic peptide HLDF-6 administration on the exproratory behavior of inbred mice C57Bl\/6 and BALB\/c strains","volume":"47","author":"Kovalev","year":"2021","journal-title":"Russ. J. Bioorgan. Chem."},{"key":"10.1016\/j.npep.2022.102287_bb0150","series-title":"Proceedings of the International Conference of Information Technologies in Medicine, Biology, Pharmacology and Ecology, Gurzuf, 02-12 June","first-page":"89","article-title":"Development of a novel neuroprotector on the basis of HLDF-6 peptide","author":"Lipkin","year":"2016"},{"key":"10.1016\/j.npep.2022.102287_bb0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neuropharm.2015.05.015","article-title":"The 5\u03b1-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson\u2019s disease","volume":"97","author":"Litim","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2022.102287_bb0160","first-page":"1","article-title":"Pathophysiology of motor dysfunction in Parkinson\u2019s disease as the rationale for drug treatment and rehabilitation","volume":"10","author":"Magrinelli","year":"2016","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.npep.2022.102287_bb0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion","volume":"73","author":"Matsuura","year":"1997","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.npep.2022.102287_bb0170","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1007\/s12035-017-0559-6","article-title":"MPTP mouse model of preclinical and clinical Parkinson\u2019s disease as an instrument for translational medicine","volume":"55","author":"Mingazov","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.npep.2022.102287_bb0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0304-3940(95)11686-Q","article-title":"Transforming growth factor-\u03b21 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson\u2019s disease","volume":"193","author":"Mogi","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2022.102287_bb0180","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mce.2008.04.008","article-title":"Estrogen and SERM neuroprotection in animal models of Parkinson\u2019s disease","volume":"290","author":"Morissette","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.npep.2022.102287_bb0185","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1046\/j.1471-4159.1996.67062434.x","article-title":"Influence of fluoxetine on regional serotonin synthesis in the rat brain","volume":"67","author":"Muck-Seler","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2022.102287_bb0190","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612053381620","article-title":"Inflammatory process in Parkinson\u2019s disease: role for cytokines","volume":"11","author":"Nagatsu","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.npep.2022.102287_bb0195","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1358\/dof.2010.035.04.1487693","article-title":"Recent developments in metabotropic glutamate receptors as novel drug targets","volume":"35","author":"O\u2019Neil","year":"2010","journal-title":"Drugs Future"},{"key":"10.1016\/j.npep.2022.102287_bb0200","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00415-016-8384-9","article-title":"The relevance of gender in Parkinson\u2019s disease: a review","volume":"264","author":"Picillo","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.npep.2022.102287_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2020.101752","article-title":"Advancement in the modelling and therapeutics of Parkinson\u2019s disease","volume":"104","author":"Rai","year":"2020","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.npep.2022.102287_bb0210","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fnagi.2017.00421","article-title":"Mucuna pruriens protects against MPTP intoxicated neuroinflammation in Parkinson\u2019s disease through NF-\u03baB\/p-Akt1 signaling pathways","volume":"9","author":"Rai","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.npep.2022.102287_bb0215","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12640-019-00038-6","article-title":"Anti-inflammatory activity of ursolic acid in MPTP-induced parkinsonian mouse model","volume":"36","author":"Rai","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.npep.2022.102287_bb0220","first-page":"730","article-title":"Singh BK Promising drug targets and associated therapeutic interventions in Parkinson\u2019s disease","volume":"16","author":"Rai","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.npep.2022.102287_bb0225","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1111\/j.1471-4159.2008.05569.x","article-title":"Gender differences and estrogen effects in parkin null mice","volume":"106","author":"Rodr\u00edguez-Navarro","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2022.102287_bb0230","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.regpep.2004.11.005","article-title":"HLDF-6 peptide affects behavioural reactions and organism functions dependent on androgen hormones in normal and castrated male mice","volume":"127","author":"Rzhevsky","year":"2005","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2022.102287_bb0235","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1111\/j.1755-5949.2010.00163.x","article-title":"Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders","volume":"16","author":"S\u00e1nchez","year":"2010","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.npep.2022.102287_bb0240","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/0269881105056645","article-title":"Does the human leukaemia differentiation factor fragment HLDF6 improve memory via brain DNA and protein synthesis?","volume":"19","author":"Sewell","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.npep.2022.102287_bb0245","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jneuroim.2004.06.011","article-title":"Interleukine-1\u03b2 and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization","volume":"158","author":"Shen","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.npep.2022.102287_bb0250","first-page":"53","article-title":"Protein HLDF and antibodies to it as molecular pathogenetic factors and new markers of acute cerebrovascular disturbances. Zhurnal Nevrologii i Psikhiatrii imeni S.S","author":"Sherstnev","year":"2004","journal-title":"Korsakova 104"},{"key":"10.1016\/j.npep.2022.102287_bb0255","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1471-4914(03)00117-5","article-title":"Disease model: Parkinson\u2019s disease","volume":"9","author":"Shimohama","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.npep.2022.102287_bb0260","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3389\/fphar.2018.00757","article-title":"Effect of chlorogenic acid supplementation in MPTP-intoxicated mouse","volume":"9","author":"Singh","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.npep.2022.102287_bb0265","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1023\/B:RUBI.0000023095.43172.c8","article-title":"The precursor of differentiation factor HLDF and ribosomal protein RPS21 have a common N-terminal sequence","volume":"30","author":"Smirnova","year":"2004","journal-title":"Russ J Bioorg Chem"},{"key":"10.1016\/j.npep.2022.102287_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111329","article-title":"Neurotropic peptide HLDF-6-amide reduces age-related decline in sexual activity in old male rats","volume":"149","author":"Sokolov","year":"2021","journal-title":"Experiment. Gerontol."},{"key":"10.1016\/j.npep.2022.102287_bb0275","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-0270(02)00360-6","article-title":"Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism","volume":"123","author":"Tillerson","year":"2003","journal-title":"J Neuroscience Methods"},{"key":"10.1016\/j.npep.2022.102287_bb0280","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.brainres.2006.02.029","article-title":"Finkelstein DI Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication","volume":"1084","author":"Tripanichkul","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2022.102287_bb0285","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuroscience.2011.03.007","article-title":"Modeling of presymptomatic and symptomatic stages of parkinsonism in mice","volume":"181","author":"Ugrumov","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2022.102287_bb0290","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/endrev\/bnz005","article-title":"The role of sex and sex hormones in neurodegenerative diseases","volume":"41","author":"Vegeto","year":"2020","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.npep.2022.102287_bb0295","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1210\/er.2016-1007","article-title":"Estrogens, neuroinflammation and neurodegeneration","volume":"37","author":"Villa","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.npep.2022.102287_bb0300","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jnc.12608","article-title":"Neuroprotective and symptomatic effects of targeting group III mGlu receptors in neurodegenerative disease","volume":"129","author":"Williams","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2022.102287_bb0305","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1023\/B:BIRY.0000040217.76635.43","article-title":"Different mechanisms of protective and differentiative activities of homological peptides TGENHR and TQVEHR","volume":"69","author":"Zhokhov","year":"2004","journal-title":"Biochem. Mosc."},{"key":"10.1016\/j.npep.2022.102287_bb0310","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1134\/S1068162015060205","article-title":"The qualitative analysis of the amide of the HLDF-6 peptide and its metabolites in tissues of laboratory animals with the use of tritium-labeled and deuterium-labeled derivatives","volume":"41","author":"Zolotarev","year":"2015","journal-title":"Russ J Bioorg Chem"},{"key":"10.1016\/j.npep.2022.102287_bb0315","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1177\/0269881116660705","article-title":"Anxiolytic activity of the neuroprotective peptide HLDF-6 and its effects on brain neurotransmitter systems in BALB\/c and C57BL\/6 mice","volume":"30","author":"Zolotarev","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.npep.2022.102287_bb0320","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1134\/S1068162020060394","article-title":"Investigation of the hydrolytic stability of the HLDF-6-AA antitumor peptide by the method of accelerated aging","volume":"46","author":"Zolotarev","year":"2020","journal-title":"Russ J Bioorg Chem"}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417922000622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417922000622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:39:36Z","timestamp":1758919176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417922000622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":64,"alternative-id":["S0143417922000622"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2022.102287","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLDF-6 peptides exhibit neuroprotective effects in the experimental model of preclinical Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2022.102287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102287"}}